• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Veterinary/Animal Vaccines Market

    ID: MRFR/Pharma/1994-CR
    133 Pages
    Kinjoll Dey
    May 2019

    Veterinary (Animal) Vaccines Market Research Report Information By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Veterinary (Animal) Vaccines Market Research Report - Forecast till 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Veterinary/Animal Vaccines Market Summary

    The Global Veterinary Vaccines Market is projected to grow from 6.27 USD Billion in 2024 to 15.4 USD Billion by 2035.

    Key Market Trends & Highlights

    Veterinary (Animal) Vaccines Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 8.48 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 15.4 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 6.27 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced vaccination technologies due to increasing awareness of animal health is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.27 (USD Billion)
    2035 Market Size 15.4 (USD Billion)
    CAGR (2025-2035) 8.48%

    Major Players

    Zoetis, Virbac SA, Merck, Phibro Animal Health Corporation, Boehringer Ingelheim, Ceva, Elanco

    Veterinary/Animal Vaccines Market Trends

    Drivers

    As the middle classes around the world explode, so does the preference to keep pets. Most people keep cats and dogs as pets.. These pets need vaccines in order to stay healthy. This is one large driver of growth in the veterinary/animal vaccines market. 

    Growing middle classes around the world means that the demand for meat consumption is rising dramatically around the world. This raises the importance of veterinary vaccines because farm animals need to be vaccinated before they are slaughtered for human consumption. 

    This keeps the meat healthier and helps it last longer. It also keeps animals from developing dangerous bacteria, parasites, and viruses that can harm or even kill humans. In fact, according to the international veterinary vaccines and diagnostics conference 2006 the demand for various types of animal vaccines will increase dramatically in later years. 

    Opportunities

    There are many emerging opportunities in the veterinary/animal vaccines market. Many veterinary clinics are investing heavily in research and development to develop and market more advanced vaccines that will keep animals healthier and stronger and help them live longer. 

    Vaccines for animals are also getting a strong boost from technological advancements. It’s advancements in technology that promise to make a new generation of stronger animal vaccines that are much more effective and last longer. 

    Research and development will also allow vaccine manufacturers to develop and market hybrid vaccines. These will be much more effective, hence they will be extremely profitable. 

    Restraints

    All vaccines have side effects. Animal vaccines are no exception. This is a key restraint in the veterinary/animal vaccines market. Most farmers and pet owners are loath to get their animals vaccinated because they are all too aware of the side effects but they are not aware enough of the benefits of these vaccines. Most farmers don’t get their animals vaccinated for this reason. This is the case in developing nations. 

    The animal vaccine market is also heavily regulated. This is another factor that’s holding back growth in the Veterinary (Animal) Vaccines Market. 

    Challenges

    Some animal vaccines for some segments of animals are very expensive. This factor is a major challenge in the veterinary/animal vaccines market. Animal vaccine manufacturers will also have to find ways to better educate animal owners about the benefits of animal vaccines. 

    Technology analysis

    Merck is a major American player in the Veterinary (Animal) Vaccines Market. It became an industry leader by creating a sustainable competitive advantage. Intensive investments in research and development have allowed it to do this. In the field of animal research, the value of vaccines has been established significantly. 

    Animals and pets have both been immunized for many years. In the near future, beekeepers might be able to immunize their colonies. As of October 2022, the first honeybee vaccine in the world is being developed by the University of Georgia College of Agricultural and Environmental Sciences (CAES) and Dalan Animal Health.

    The ongoing advancements in veterinary vaccine development are poised to enhance animal health outcomes and may contribute to the overall sustainability of livestock production systems.

    U.S. Department of Agriculture (USDA)

    Veterinary/Animal Vaccines Market Drivers

    Rising Pet Ownership

    The increasing trend of pet ownership globally is a primary driver for the Global Veterinary Animal Vaccines Market Industry. As more households adopt pets, the demand for veterinary services, including vaccinations, rises significantly. In 2024, the market is valued at 6.27 USD Billion, reflecting the growing concern among pet owners for their animals' health. This trend is particularly pronounced in urban areas, where pet ownership rates have surged. Consequently, the need for effective vaccines to prevent diseases in pets is becoming more critical, thereby propelling the market forward.

    Market Growth Projections

    The Global Veterinary Animal Vaccines Market Industry is projected to experience substantial growth in the coming years. With a market value of 6.27 USD Billion in 2024, it is anticipated to reach 15.4 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate of 8.48% from 2025 to 2035. Such projections reflect the increasing demand for veterinary vaccines driven by factors such as rising pet ownership, advancements in vaccine technology, and heightened awareness of animal health. The market's expansion is indicative of the critical role that vaccines play in ensuring the health and well-being of animals globally.

    Emerging Zoonotic Diseases

    The emergence of zoonotic diseases is a significant driver for the Global Veterinary Animal Vaccines Market Industry. As new diseases that can be transmitted from animals to humans arise, there is an urgent need for effective vaccination strategies to control outbreaks. This concern is particularly relevant in regions where livestock and wildlife interactions are frequent. The increasing incidence of such diseases highlights the necessity for robust vaccination programs, thereby propelling market growth. The focus on preventing zoonotic diseases is expected to contribute to the overall expansion of the market in the coming years.

    Regulatory Support and Standards

    Regulatory frameworks and standards established by government agencies play a crucial role in shaping the Global Veterinary Animal Vaccines Market Industry. Governments worldwide are implementing stringent regulations to ensure the safety and efficacy of veterinary vaccines. This regulatory support fosters consumer confidence and encourages veterinarians to adopt new vaccines. Moreover, compliance with these regulations often leads to improved product quality, which can enhance market growth. As the industry evolves, adherence to these standards will likely remain a key driver for the market, ensuring that animal health is prioritized.

    Advancements in Vaccine Technology

    Technological advancements in vaccine development are transforming the Global Veterinary Animal Vaccines Market Industry. Innovations such as recombinant vaccines and mRNA technology are enhancing vaccine efficacy and safety. These advancements not only improve the immune response in animals but also reduce the incidence of adverse effects. As a result, veterinarians are more likely to recommend these modern vaccines, further driving market growth. The anticipated market expansion to 15.4 USD Billion by 2035 underscores the importance of these technological developments in meeting the evolving needs of animal health.

    Increased Awareness of Animal Health

    There is a growing awareness among pet owners and livestock producers regarding the importance of animal health, which significantly influences the Global Veterinary Animal Vaccines Market Industry. Educational campaigns and outreach programs by veterinary associations have heightened understanding of the benefits of vaccinations. This awareness leads to increased vaccination rates, thereby reducing the prevalence of infectious diseases in animals. As the market continues to expand, the projected compound annual growth rate of 8.48% from 2025 to 2035 indicates that this trend will likely persist, further solidifying the role of vaccines in animal health.

    Market Segment Insights

    Veterinary/Animal Vaccines Type Insights

    The veterinary/animal vaccines market can be grouped into the following sub-segments by type:

    The attenuated vaccines sub-segment held the highest market share last year because they do a better job of boosting animals’ immune systems than other vaccines do. Also, animals who get attenuated vaccines need fewer booster shots less often. Most booster vaccines are given to animals orally. 

    This makes them less effective in strengthening the animals’ immune systems and keeping them healthier than vaccines that are given by injection. 

    The companion animal vaccines are given to cats and dogs. Livestock vaccines tend to be given to farm animals. The livestock vaccine market had the highest market share in 2020. The reason was that these animals tend to be vaccinated more frequently and more often than companion animals. 

    Veterinary/Animal Vaccines Disease Insights

    The Veterinary (Animal) Vaccines Market can be grouped into the following sub-segments by disease:

    Veterinary/Animal Vaccines Technology Insights

    The Veterinary (Animal) Vaccines Market can be grouped into the following sub-segments by type:

    By Type (Livestock)

    The Department of Animal Husbandry and Dairying (DAHD) advised states to immunize cattle and buffaloes with the available Goat pox vaccine on September 20, 2021, despite the fact that lumpy skin disease has already killed almost 1 lakh cattle and infected over 20 lakh animals across 15 states. The only manufacturer of the goatpox vaccine in the nation at the time of authorization was Hester Biosciences in Gujarat; IIL, the Hyderabad-based Brilliant Bio Pharma Pvt Ltd, introduced its goatpox vaccine in December 2021.

    Regional analysis

    The veterinary/animal vaccines market can be divided into the following geographic regions:

    Get more detailed insights about Veterinary (Animal) Vaccines Market Research Report - Forecast till 2032

    Regional Insights

    Key Companies in the Veterinary/Animal Vaccines Market market include

    Industry Developments

      • Many key companies in the Veterinary (Animal) Vaccines Market have stayed successful by entering into strategic partnerships with other successful companies. They have managed to develop a new vaccine for poultry (chicks to be exact). This is very effective so it has great revenue generation potential.
      • Big companies are partnering up to develop new aquaculture vaccines that will do a better job of protecting aquatic life from diseases.
      • Elanco acquired a new animal vaccine company as part of its expansion strategy

    Future Outlook

    Veterinary/Animal Vaccines Market Future Outlook

    The Veterinary (Animal) Vaccines Market is projected to grow at an 8.48% CAGR from 2024 to 2035, driven by increasing pet ownership, advancements in vaccine technology, and rising awareness of animal health.

    New opportunities lie in:

    • Develop personalized vaccines targeting specific animal breeds.
    • Leverage digital platforms for vaccine distribution and education.
    • Invest in R&D for innovative adjuvants to enhance vaccine efficacy.

    By 2035, the Veterinary (Animal) Vaccines Market is expected to achieve substantial growth, reflecting evolving industry dynamics.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
      Market Size 2032   11.8 (USD) Billion
      CAGR   9.2% (2023-2032)
      Base Year   2022
      Forecast Period   2023-2032
      Historical Data   2020
      Forecast Units   Value (USD Billion)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Type, Technology, Region
      Geographies Covered   North America, Europe, Asia-Pacific, Rest of the World
      Key Vendors   Zoetis (US), Virbac SA (France), Merck (US), Phibro Animal Health Corporation (US), Boehringer Ingelheim (Germany), Ceva (France), Elanco (US)
      Key Market Opportunities ·  High development opportunities in the upcoming years ·  Technological developments
      Key Market Drivers ·  The increasing rate of pet adoption ·  Rising expenditure on the pet treatment ·  High consumption of meat

    Market Highlights

    Author
    Kinjoll Dey
    Research Analyst Level I

    He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

    Leave a Comment

    FAQs

    Which regions will have the highest CAGR in veterinary/animal vaccines market?

    North America and Asia-Pacific

    What are the recent trends in the veterinary/animal vaccines market?

    More technological advancement is leading to better and more innovative vaccines

    Who are the key competitors in the veterinary/animal vaccines market?

    Zoetis (US), Virbac SA (France), Merck (US), Phibro Animal Health Corporation (US), Boehringer Ingelheim (Germany), Ceva (France), Elanco (US)

    1. Report Prologue
    2. Executive Summary
    3. Market Introduction
      1. Definition 18
      2. Scope of the Study 18
      3. Research Objective 18
      4. Assumptions & Limitations 18
        1. Assumptions 18
        2. Limitations
      5. Market Structure 19
    4. Research Methodology
      1. Research Process
      2. Primary Research 22
      3. Secondary Research 23
      4. Market Size
    5. Estimation 24
      1. Forecast Model 24
    6. Market Dynamics
      1. Introduction
      2. Drivers 27
        1. Increasing Number of Pet Owners 27
    7. Growing Livestock Population and Disease Outbreaks 27
      1. Advances in Technology
    8. underlying Veterinary Vaccines 27
      1. Various Initiatives by Several Government
    9. Agencies, Animal Associations, and Prominent Market Players 28
      1. Restraint
        1. High Storage Cost associated with Veterinary Vaccines 28
    10. Opportunity 28
      1. Rising Investments to Improve Animal Health 28
    11. Market Factor Analysis
      1. Porter’s Five Forces Model 30
        1. Bargaining
    12. Power of Suppliers 30
      1. Bargaining Power of Buyers 31
        1. Threat
    13. of New Entrants 31
      1. Threat of Substitutes 31
        1. Rivalry 31
      2. Supply Chain Analysis 31
        1. R&D and Development 32
    14. Manufacturing 32
      1. Distribution & Sales 32
        1. Post-Sales Monitoring
    15. Veterinary (Animal) Vaccines Market, by Type
      1. Introduction 35
        1. Livestock Vaccines 37
        2. Porcine Vaccines 38
        3. Companion
    16. Animal Vaccines 38
      1. Poultry Vaccines 39
        1. Aquaculture Vaccines
    17. Veterinary (Animal) Vaccines Market, by Technology
      1. Introduction
        1. Live Attenuated Vaccines 43
        2. Inactivated Vaccines 43
        3. Recombinant Vaccines 44
        4. Toxoid Vaccines 44
    18. Global Veterinary
    19. (Animal) Vaccines Market, by Region
      1. Introduction 46
      2. Americas 48
    20. Veterinary (Animal) Vaccines Market, by Type
    21. Veterinary (Animal) Vaccines
    22. Market, by Technology
      1. North America 51
    23. Veterinary (Animal) Vaccines
    24. Market, by Type
    25. Veterinary (Animal) Vaccines Market, by Technology
    26. US 53
    27. Veterinary (Animal) Vaccines Market, by Type
    28. Veterinary (Animal)
    29. Vaccines Market, by Technology
      1. Canada 55
    30. Veterinary (Animal) Vaccines
    31. Market, by Type
    32. Veterinary (Animal) Vaccines Market, by Technology
    33. South America 57
    34. Veterinary (Animal) Vaccines Market, by Type
    35. Veterinary
    36. (Animal) Vaccines Market, by Technology
      1. Europe 60
    37. Veterinary (Animal)
    38. Vaccines Market, by Type
    39. Veterinary (Animal) Vaccines Market, by Technology
      1. Western Europe 63
    40. Veterinary (Animal) Vaccines Market, by Type
    41. Veterinary
    42. (Animal) Vaccines Market, by Technology
      1. France 65
    43. Veterinary (Animal)
    44. Vaccines Market, by Type
    45. Veterinary (Animal) Vaccines Market, by Technology
      1. Germany 67
    46. Veterinary (Animal) Vaccines Market, by Type
    47. Veterinary
    48. (Animal) Vaccines Market, by Technology
      1. UK 69
    49. Veterinary (Animal)
    50. Vaccines Market, by Type
    51. Veterinary (Animal) Vaccines Market, by Technology
      1. Spain 71
    52. Veterinary (Animal) Vaccines Market, by Type
    53. Veterinary
    54. (Animal) Vaccines Market, by Technology
      1. Italy 73
    55. Veterinary (Animal)
    56. Vaccines Market, by Type
    57. Veterinary (Animal) Vaccines Market, by Technology
      1. Rest of Western Europe 75
    58. Veterinary (Animal) Vaccines Market, by
    59. Type
    60. Veterinary (Animal) Vaccines Market, by Technology
      1. Eastern
    61. Europe 77
    62. Veterinary (Animal) Vaccines Market, by Type
    63. Veterinary (Animal)
    64. Vaccines Market, by Technology
      1. Asia-Pacific 80
    65. Veterinary (Animal)
    66. Vaccines Market, by Type
    67. Veterinary (Animal) Vaccines Market, by Technology
      1. Japan 83
    68. Veterinary (Animal) Vaccines Market, by Type
    69. Veterinary
    70. (Animal) Vaccines Market, by Technology
      1. China 85
    71. Veterinary (Animal)
    72. Vaccines Market, by Type
    73. Veterinary (Animal) Vaccines Market, by Technology
      1. India 87
    74. Veterinary (Animal) Vaccines Market, by Type
    75. Veterinary
    76. (Animal) Vaccines Market, by Technology
      1. Australia 89
    77. Veterinary
    78. (Animal) Vaccines Market, by Type
    79. Veterinary (Animal) Vaccines Market, by Technology
      1. Republic of Korea 91
    80. Veterinary (Animal) Vaccines Market, by Type
    81. Veterinary (Animal) Vaccines Market, by Technology
      1. Rest of Asia-Pacific
    82. Veterinary (Animal) Vaccines Market, by Type
    83. Veterinary (Animal) Vaccines
    84. Market, by Technology
      1. Middle East and Africa 95
    85. Veterinary (Animal)
    86. Vaccines Market, by Type
    87. Veterinary (Animal) Vaccines Market, by Technology
      1. Middle East 98
    88. Veterinary (Animal) Vaccines Market, by Type
    89. Veterinary
    90. (Animal) Vaccines Market, by Technology
      1. Africa 100
    91. Veterinary (Animal)
    92. Vaccines Market, by Type
    93. Veterinary (Animal) Vaccines Market, by Technology
    94. Competitive Landscape
      1. Introduction 103
    95. Company Profiles
      1. Boehringer Ingelheim International GmbH 106
        1. Company Overview
        2. Financial Overview 106
        3. Products/Services Offered 107
        4. Key Developments 107
        5. SWOT Analysis 107
        6. Key Strategies
      2. Zoetis 108
        1. Company Overview 108
        2. Financial
    96. Overview 108
      1. Products/Services Offered 109
        1. Key Developments
        2. SWOT Analysis 110
        3. Key Strategies 110
      2. Ceva
        1. Company Overview 111
        2. Financial Overview 111
    97. Products/Services Offered 112
      1. Key Developments 112
        1. SWOT
    98. Analysis 113
      1. Key Strategies 113
      2. MSD & Co. Inc. 114
        1. Company Overview 114
        2. Financial Overview 114
        3. Products/Services
    99. Offered 115
      1. Key Developments 116
        1. SWOT Analysis 116
    100. Key Strategies 116
      1. Elanco 117
        1. Company Overview 117
    101. Financial Overview 117
      1. Products/Services Offered 118
        1. Key
    102. Developments 118
      1. SWOT Analysis 118
        1. Key Strategies 119
      2. Virbac 120
        1. Company Overview 120
        2. Financial Overview
        3. Products/Services Offered 121
        4. Key Developments 121
        5. SWOT Analysis 121
        6. Key Strategies 121
      3. Phibro Animal
    103. Health Corporation. 122
      1. Company Overview 122
        1. Financial Overview
        2. Products/Services Offered 123
        3. Key Developments 123
        4. SWOT Analysis 123
        5. Key Strategies 123
      2. Hipra 124
        1. Company Overview 124
        2. Financial Overview 124
        3. Products/Services
    104. Offered 124
      1. Key Developments 125
        1. SWOT Analysis 125
    105. Key Strategies 125
      1. IDT Biologika GmbH 126
        1. Company Overview
        2. Financial Overview 126
        3. Products/Services Offered 126
        4. Key Developments 126
        5. SWOT Analysis 127
        6. Key Strategies
      2. Biogenesis Bago SA 128
        1. Company Overview 128
    106. Financial Overview 128
      1. Products/Services Offered 128
        1. Key
    107. Developments 128
      1. SWOT Analysis 129
        1. Key Strategies 129
    108. Appendix
      1. Discussion Blue Print 131
    109. List of Tables
    110. MARKET SYNOPSIS 16
    111. (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 36
    112. GLOBAL Veterinary (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
    113. (USD MILLION) 36
    114. ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 37
    115. (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY REGION, 2020–2027 (USD
    116. MILLION) 37
    117. VACCINES, BY REGION, 2020–2027 (USD MILLION) 38
    118. (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY REGION, 2020–2027
    119. (USD MILLION) 38
    120. POULTRY VACCINES, BY REGION, 2020–2027 (USD MILLION) 39
    121. Veterinary (Animal) Vaccines Market, FOR AQUACULTURE VACCINES, BY REGION, 2020–2027
    122. (USD MILLION) 39
    123. –2027 (USD MILLION) 42
    124. Market, FOR LIVE ATTENUATED VACCINES, BY REGION, 2020–2027 (USD MILLION) 43
    125. BY REGION, 2020–2027 (USD MILLION) 43
    126. Vaccines Market, FOR RECOMBINANT VACCINES, BY REGION, 2020–2027 (USD MILLION)
    127. BY REGION, 2020–2027 (USD MILLION) 44
    128. Vaccines Market, BY REGION, 2020–2027 (USD MILLION) 47
    129. Veterinary (Animal) Vaccines Market, BY REGION, 2020–2027 (USD MILLION) 48
    130. (USD MILLION) 49
    131. LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 49
    132. Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    133. (USD MILLION) 50
    134. BY TECHNOLOGY, 2020–2027 (USD MILLION) 50
    135. (Animal) Vaccines Market, BY COUNTRY, 2020–2027 (USD MILLION) 51
    136. NORTH AMERICA: Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027
    137. (USD MILLION) 51
    138. FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 52
    139. NORTH AMERICA: Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES,
    140. BY TYPE, 2020–2027
    141. (USD MILLION) 52
    142. (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION) 53
    143. US: Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION)
    144. BY TYPE, 2020–2027 (USD MILLION) 54
    145. Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION)
    146. (USD MILLION) 55
    147. –2027 (USD MILLION) 55
    148. Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 56
    149. CANADA: Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY
    150. TYPE, 2020–2027 (USD MILLION) 56
    151. Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION) 57
    152. AMERICA: Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION)
    153. VACCINES, BY TYPE, 2020–2027 (USD MILLION) 58
    154. Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    155. (USD MILLION) 58
    156. BY TECHNOLOGY, 2020–2027 (USD MILLION) 59
    157. (Animal) Vaccines Market, BY REGION, 2020–2027 (USD MILLION) 60
    158. EUROPE: Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION)
    159. BY TYPE, 2020–2027 (USD MILLION) 61
    160. Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION)
    161. (USD MILLION) 62
    162. BY COUNTRY, 2020–2027 (USD MILLION) 63
    163. (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 63
    164. WESTERN EUROPE: Veterinary (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY
    165. TYPE, 2020–2027 (USD MILLION) 64
    166. (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    167. (USD MILLION) 64
    168. BY TECHNOLOGY, 2020–2027 (USD MILLION) 65
    169. (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 65
    170. FRANCE: Veterinary (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
    171. (USD MILLION) 66
    172. COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 66
    173. FRANCE: Veterinary (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD
    174. MILLION) 67
    175. –2027 (USD MILLION) 67
    176. Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 68
    177. GERMANY: Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES,
    178. BY TYPE, 2020–2027
    179. (USD MILLION) 68
    180. (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION) 69
    181. UK: Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION)
    182. BY TYPE, 2020–2027 (USD MILLION) 70
    183. Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION)
    184. (USD MILLION) 71
    185. –2027 (USD MILLION) 71
    186. Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 72
    187. SPAIN: Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY
    188. TYPE, 2020–2027 (USD MILLION) 72
    189. Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION) 73
    190. Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 73
    191. TYPE, 2020–2027 (USD MILLION) 74
    192. Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION)
    193. (USD MILLION) 75
    194. Market, BY TYPE, 2020–2027 (USD MILLION) 75
    195. EUROPE: Veterinary (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
    196. (USD MILLION) 76
    197. Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 76
    198. –2027 (USD MILLION) 77
    199. Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 77
    200. EUROPE: Veterinary (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
    201. (USD MILLION) 78
    202. FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    203. (USD MILLION) 78
    204. (USD MILLION) 79
    205. BY COUNTRY, 2020–2027 (USD MILLION) 80
    206. (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 81
    207. ASIA-PACIFIC: Veterinary (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE,
    208. –2027 (USD MILLION) 81
    209. Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    210. (USD
    211. MILLION) 82
    212. TECHNOLOGY, 2020–2027 (USD MILLION) 82
    213. Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 83
    214. Veterinary (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
    215. (USD MILLION) 83
    216. ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 84
    217. Veterinary (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION)
    218. (USD MILLION) 85
    219. VACCINES, BY TYPE, 2020–2027 (USD MILLION) 85
    220. (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    221. (USD MILLION) 86
    222. –2027 (USD MILLION) 86
    223. Market, BY TYPE, 2020–2027 (USD MILLION) 87
    224. (Animal) Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD
    225. MILLION) 87
    226. ANIMAL VACCINES, BY TYPE, 2020–2027 (USD MILLION) 88
    227. Veterinary (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION)
    228. (USD MILLION) 89
    229. LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 89
    230. Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    231. (USD MILLION) 90
    232. BY TECHNOLOGY, 2020–2027 (USD MILLION) 90
    233. Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION) 91
    234. VACCINES, BY TYPE, 2020–2027
    235. (USD MILLION) 91
    236. OF KOREA: Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY
    237. TYPE, 2020–2027
    238. (USD MILLION) 92
    239. (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92
    240. REST OF ASIA-PACIFIC: Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027
    241. (USD MILLION) 93
    242. Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027
    243. (USD MILLION) 93
    244. ANIMAL VACCINES, BY TYPE, 2020–2027
    245. (USD MILLION) 94
    246. OF ASIA-PACIFIC: Veterinary (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027
    247. (USD MILLION) 94
    248. Market, BY REGION, 2020–2027 (USD MILLION) 95
    249. AFRICA: Veterinary (Animal) Vaccines Market, BY TYPE, 2020–2027 (USD MILLION)
    250. LIVESTOCK VACCINES, BY TYPE, 2020–2027
    251. (USD MILLION) 96
    252. MIDDLE EAST AND AFRICA: Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL
    253. VACCINES, BY TYPE, 2020–2027 (USD MILLION) 97
    254. AFRICA: Veterinary (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD
    255. MILLION) 97
    256. TYPE, 2020–2027 (USD MILLION) 98
    257. Vaccines Market, FOR LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION)
    258. ANIMAL VACCINES, BY TYPE, 2020–2027
    259. (USD MILLION) 99
    260. EAST: Veterinary (Animal) Vaccines Market, BY TECHNOLOGY, 2020–2027 (USD MILLION)
    261. (USD MILLION) 100
    262. LIVESTOCK VACCINES, BY TYPE, 2020–2027 (USD MILLION) 100
    263. Veterinary (Animal) Vaccines Market, FOR COMPANION ANIMAL VACCINES, BY TYPE, 2020–2027
    264. (USD MILLION) 101
    265. TECHNOLOGY, 2020–2027 (USD MILLION) 101
    266. List of Figures
    267. RESEARCH PROCESS 21
    268. MARKET DYNAMICS: ANALYSIS OF THE GLOBAL Veterinary (Animal) Vaccines Market 26
    269. Market 30
    270. (% SHARE) 41
    271. REGION, 2020 (% SHARE) 46
    272. BY REGION, 2020 & 2027 (USD MILLION) 46
    273. (Animal) Vaccines Market SHARE, BY REGION, 2020 (% SHARE) 48
    274. Veterinary (Animal) Vaccines Market SHARE, BY REGION, 2020 (% SHARE) 60
    275. ASIA-PACIFIC: Veterinary (Animal) Vaccines Market SHARE, BY COUNTRY, 2020 (%
    276. SHARE) 80
    277. SHARE, BY REGION, 2020 (% SHARE) 95
    278. Market, MARKET SHARE ANALYSIS 2020 (%) 103

    Veterinary (Animal) Vaccines Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Veterinary (Animal) Vaccines Market Research Report - Forecast till 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials